Who
Frazier Life Sciences XI, L.P.
10% owner
Company insider
Files Form 4 as: 10% owner, Attovia Therapeutics.
In numbers
- Trades disclosed
- 9
- Buys
- 1
- Sells
- 0
- Bought
- $10.0M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 6 Aug 2026
- Last trade
- 6 Aug 2026
- Last filed
- 6 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 6 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Code C | —1,749,192 | filing |
| 6 Aug 2026filed 6 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Code C | —1,590,175 | filing |
| 6 Aug 2026filed 6 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Code C | —1,189,940 | filing |
| 6 Aug 2026filed 6 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Code C | —961,322 | filing |
| 6 Aug 2026filed 6 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Bought | $10.0M588,235 at $17.00 | filing |
| 6 Aug 2026filed 6 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —16,250,000 at $0.00 | filing |
| 6 Aug 2026filed 6 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —14,772,727 at $0.00 | filing |
| 6 Aug 2026filed 6 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —11,054,544 at $0.00 | filing |
| 6 Aug 2026filed 6 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —8,930,685 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.